Study Now Recruiting - ARQ 092

To learn more about the currently enrolling clinical trial, “A Phase 1/2 Study of ARQ 092 in Patients with Overgrowth Diseases and Vascular Anomalies with Genetic Alterations of the PI3K/AKT Pathway,” please click here for information on You may also contact Yvonne Sheldon, RN, BSN at Boston Children’s Hospital at 617-919-6299 or  [email protected].

Page last updated January 9, 2018